CX3CL1 and type 2 diabetes mellitus: Fractalkine (CX3CL1), which acts as a chemoattractant and adhesion factor, is released from adipocytes and plays a pivotal role in recruiting inflammatory cells and facilitating their settlement at inflammation sites, such as expanding white adipose tissue in cases of obesity and T2D [14].